Edward Nash is a Managing Director and Senior Analyst covering the biotechnology and life sciences sector at SunTrust Robinson Humphrey. He brings 17 years of experience from both the buy side and sell side, joining SunTrust Robinson Humphrey from Cowen and Company. Mr. Nash earned his MBA in finance and M.S. in international business from the University of Miami, as well as a Master of Public Health in epidemiology from the University of Alabama at Birmingham. He completed his bachelor’s degree in biology at Spring Hill College.
Biotech and Pharma Companies Set For Milestones in 2018
March 08, 2018
Gene Therapy Space Grows More Disruptive and Competitive
April 21, 2017
High Investor Expectations for the Biotech Sector
January 15, 2016
